641569-94-0 (4-甲基-3-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯甲酸,4-Methyl-3-4-(3-pyridinyl)-2-pyrimidinylaminobenzoic acid)

CAS号:
641569-94-0
中文名称:
4-甲基-3-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯甲酸
英文名称:
4-Methyl-3-4-(3-pyridinyl)-2-pyrimidinylaminobenzoic acid
分子式:
C17H14N4O2
分子量:
306.31866312027

4-甲基-3-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯甲酸(641569-94-0)名称与标识符

名称

中文别名:
4-甲基-3-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯甲酸;4-甲基-3-[[4-(3-吡啶-4-甲基)-2-嘧啶基]氨基]苯甲酸;尼罗替尼中间体1;尼罗替尼中间体2;尼罗替尼中间体4-甲基-3-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯甲酸;4-甲基-3-((4-(3-吡啶基)-2-嘧啶基)氨基)苯甲酸;尼洛替尼中间体2;
英文别名:
4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoic acid;4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzoic acid;4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid;4-METHYL-3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]-BENZOIC ACID;4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid);Benzoic acid, 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-;Temsirolimus;3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)-4-methylbenzoic acid;4-methyl-3-(4-(pyridine-3-yl)pyrimidin-2-ylamino)benzoic acid;4-methyl-3-[[4-(3-pyridyl)-2-pyrimidinyl]amino]benzoic acid;4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}benzoic acid;BEN74;Benzoic acid,4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino];TQ9WCS4PF0;4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)benzoic acid;4-Methyl-3-((4-(3-pyridyl)pyrimidin-2-yl)amino)benzoic acid;4-methyl-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]benzoic acid;4-methyl;PS-7101;4-(5-amino-6-hydroxy-2-benzoxazolyl)-benzoicacid;641569-94-0;AC-8510;MFCD11521324;BCP04528;Benzoic acid, 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-; 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid; Nilotinib Hydrochloride Monohydrate Impurity D; Nilotinib Impurity D;LDLZPHLSVKGFSC-UHFFFAOYSA-N;NILOTINIB HYDROCHLORIDE MONOHYDRATE IMPURITY D [EP IMPURITY];A8804;SY107567;UNII-TQ9WCS4PF0;Nilotinib hydrochloride monohydrate impurity D [EP];DTXSID90439380;AKOS015888621;Benzoic acid, 4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-;CS-0009198;Q-101350;C17H14N4O2;FT-0655847;4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoicacid;AM20090654;4-Methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]benzoic Acid;4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)benzoic acid;4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoic acid;SB57892;SCHEMBL533540;NILOTINIB HYDROCHLORIDE MONOHYDRATE IMPURITY D (EP IMPURITY);Nilotinib hydrochloride monohydrate impurity D;

标识符

MDL:
MFCD11521324
InChIKey:
LDLZPHLSVKGFSC-UHFFFAOYSA-N
Inchi:
1S/C17H14N4O2/c1-11-4-5-12(16(22)23)9-15(11)21-17-19-8-6-14(20-17)13-3-2-7-18-10-13/h2-10H,1H3,(H,22,23)(H,19,20,21)
SMILES:
OC(C1C=CC(C)=C(C=1)NC1N=CC=C(C2C=NC=CC=2)N=1)=O

4-甲基-3-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯甲酸(641569-94-0)物化性质

实验特性

  • LogP : 3.36180
  • PSA : 88.00000
  • 折射率 : 1.676
  • 沸点 : 587.9°C at 760 mmHg
  • 熔点 : 268-271°C
  • 闪点 : 309.4±32.9 °C
  • 颜色与性状 : No data available
  • 密度 : 1.336

计算特性

  • 精确分子量 : 306.11200
  • 氢键供体数量 : 2
  • 氢键受体数量 : 6
  • 可旋转化学键数量 : 4
  • 同位素质量 : 306.11167570g/mol
  • 重原子数量 : 23
  • 复杂度 : 406
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 2.6
  • 拓扑分子极性表面积 : 88

4-甲基-3-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯甲酸(641569-94-0)海关数据

海关编码:
2933990090
海关数据:

中国海关编码:

2933990090

概述:

2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

申报要素:

品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期

Summary:

2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

4-甲基-3-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯甲酸(641569-94-0)推荐厂家 更多厂家(93)

4-甲基-3-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯甲酸(641569-94-0)上下游

4-甲基-3-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯甲酸(641569-94-0)参考资料

Beilstein:
M194362
PubChem CID: